ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2015 American Transplant Congress

    Everolimus Initiation Immediately After Liver Transplantation: A Single-Center Experience

    U. Herden, A. Galante, S. Pischke, L. Fischer, J. Li, M. Koch, E. Achilles, B. Nashan, M. Sterneck.

    University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

    BackgroundClinical trials in liver transplant (LTX) patients with randomization on day 30 to everolimus (EVR) show a benefit in renal function compared to calcineurin inhibitor…
  • 2015 American Transplant Congress

    Elevated Cancer Risk Among US Pediatric Solid Organ Transplant Recipients

    E. Yanik,1 J. Smith,2 M. Shiels,1 C. Clarke,3 C. Lynch,4 A. Kahn,5 L. Koch,6 K. Pawlish,7 E. Engels.1

    1Natl. Cancer Inst., Bethesda, MD; 2Seattle Children's Hosp., Seattle, WA; 3Cancer Prev. Inst. of CA, Fremont, CA; 4U. of Iowa, Iowa City, IA; 5NY St. Cancer Reg., Albany, NY; 6IL St. Cancer Reg., Springfield, IL; 7NJ St. Cancer Reg., Trenton, NJ.

    Among pediatric transplant recipients, the effects of transplantation and immunosuppression on cancer risk may be unique from those observed in the adult transplant population. No…
  • 2015 American Transplant Congress

    Donor and Recipient Pretransplant Polyoma BK Serostatus: Relationship to BK-Viremia After Renal Transplantation

    H. Tseng, R. Lopez-Soler, N. Chandolias, T. Friedrich, J. Eldor, D. Conti.

    Surgery, Albany Medical College, Albany, NY.

    Background:Polyoma virus BK nephropathy is a serious complication after renal transplantation and is associated with a significant risk of graft loss and dysfunction. This study…
  • 2015 American Transplant Congress

    Patient Outcomes After Listing for Kidney Alone Transplantation in Potential Recipients Aged Over 70 Years

    D. Kanigicherla, M. Morton, I. Zia, J. Worthington, S. Sofia, T. Augustine, M. Picton.

    Manchester Institute of Nephrology & Transplantation, Central Manchester University Hospitals NHS Trust, Manchester, United Kingdom.

    BackgroundLow likelihood of listing and subsequent deceased donor transplantation has previously been reported for the elderly with additional concerns about patient frailty, morbidity and mortality…
  • 2015 American Transplant Congress

    Sevoflurane Based Anesthesia in Recipients Reduces 2 Year Acute Rejection in Living Donor Kidney Transplantation. Results from the VAPOR-Trial

    G. Nieuwenhuijs-Moeke,1 V. Nieuwenhuijs,2 M. Seelen,3 R. Ploeg,2 H. Leuvenink,2 M. Struys.1

    1Anesthesiology, University Medical Center, Groningen, Netherlands; 2Surgery, University Medical Center, Groningen, Netherlands; 3Nephrology, University Medical Center, Groningen, Netherlands.

    IntroductionVolatile anesthetic agents like sevoflurane may protect against the ischemia and reperfusion injury (IRI) that is inevitable part of organ donation and transplantation. It is…
  • 2015 American Transplant Congress

    Recipient IL-33 Promotes Type 1 Alloimmunity and Lethal Acute GVHD Following alloHCT

    B. Matta,1 D. Reichenbach,2 V. Schwarze,3 V. Tkachev,4 L. Mathews,1 Q. Liu,1 M. Warncke,5 J. Ferrara,4 R. Zeiser,3 B. Blazar,2 H. Turnquist.1

    1Surgery, Univ. of Pittsburgh, Pittsburgh, PA; 2Pediatrics, Univ. of Minnesota, Minneapolis, MN; 3Hematology and Oncology, Univ. Medical Center Freiburg, Freiburg, Germany; 4Pediatrics, Univ. of Michigan, Ann Arbor, MI; 5Novartis Institute for Biomedical Research, Basel, Switzerland.

    Background: Graft-versus-host disease (GVHD) is a common complication of allogeneic (allo) hematopoietic cell transplantation (HCT) that limits its widespread application for the induction of transplant…
  • 2015 American Transplant Congress

    Impact of Human Mutant TGF-β1/Fc Protein On Memory and Regulatory CD4+T Cells Following Lymphodepletion in Rhesus Monkeys

    H. Guo,1 L. Lu,1 R. Wang,2 H. Abdulkerim,2 R. Keith,2 A. Thomson,1 M. Ezzelarab.1

    1Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA; 2MassBiologics, University of Massachusetts Medical School, Boston, MA.

    Background:Tolerance to allografts is essential to avoid chronic immunosuppression and to promote long term graft function. Transforming growth factor- β plays a key role in…
  • 2015 American Transplant Congress

    Donor Organ Resident M2 Type Myeloid Cells Protect Murine Orthotropic Liver Transplants from Ischemia and Reperfusion Injury

    S. Yue, X. Shen, F. Gao, R. Busuttil, J. Kupiec-Weglinski, Y. Zhai.

    The Dumont-UCLA Transplant Ctr., UCLA, Los Angeles, CA.

    Liver ischemia reperfusion injury (lRI) is mediated by a pro-inflammatory immune response initiated by the activation of liver non-parenchymal innate immune cells, such as Kupffer…
  • 2015 American Transplant Congress

    Monocyte Recruitment to HLA Class I Antibody-Activated Endothelial Cells Is Dependent Upon mTOR

    S. Salehi, E. Reed.

    Pathology & Laboratory Medicine, UCLA, Los Angeles, CA.

    Aim: Antibody-mediated rejection (AMR) persists as a major issue affecting solid organ transplants. The purpose of this study was to investigate the proximal signaling events…
  • 2015 American Transplant Congress

    Cognate Events in Antibody- Vs. T Cell-Mediated Rejection: A Molecular Perspective

    M. Parkes,1 P. Halloran,1 L. Hidalgo.2

    1Department of Medicine, University of Alberta, Edmonton, AB, Canada; 2Department of Laboratory Medicine & Pathology, University of Alberta, Edmonton, AB, Canada.

    AIM: The cognate event in antibody-mediated rejection (ABMR) is NK cell FcR engagement; T cell mediated rejection (TCMR) uses TCR engagement. Understanding the molecular changes…
  • « Previous Page
  • 1
  • …
  • 139
  • 140
  • 141
  • 142
  • 143
  • …
  • 170
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences